GlassScriptPhysician profile
John G Linn
NPI 1750538880
$222,273.69
in general payments reported to CMS, 2019-2025
11 companies · $65K in 2025
The $65K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $6,626 · 2021: $37.55 · 2022: $10K · 2023: $44K · 2024: $82K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $169K · Travel and Lodging: $15K · Food and Beverage: $6,265 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,000 · Education: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $168,750.00 |
| Travel and Lodging | $14,928.40 |
| Food and Beverage | $6,265.43 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,000.00 |
| Education | $442.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $219,171.69 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement |
| Medtronic, INC. | $1,255.03 | 2021-2025 | Signia, Transorb |
| Intuitive Surgical, INC. | $1,027.23 | 2023-2025 | |
| Tela Bio, INC. | $193.67 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $170.71 | 2023-2024 | Peri-Strips Dry, Perclot |
| Ethicon US, LLC | $167.50 | 2023-2024 | Echelon Endopath, Harmonic, Echelon Circular |
| Apollo Endosurgery US INC | $115.37 | 2023 | Overstitch Endoscopic Suturing System |
| Boston Scientific Corporation | $53.10 | 2025 | Apollo Esg Nxt System |
| Pacira Pharmaceuticals Incorporated | $47.69 | 2025 | Exparel |
| Conmed Corporation | $38.46 | 2024 | Airseal |
| Covidien LP | $33.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Linn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.